Why the study?
Caffeic acid phenethyl ester possesses antioxidant and anticancer effects, motivating investigation into its effectiveness on the cytotoxicity of doxorubicin and cisplatin in stomach and colon cancer cells.
Does CAPE enhance the sensitivity of gastric and colon cancer cells to doxorubicin and cisplatin?
Population
Parental and drug-resistant stomach (MKN45) and colon (LoVo) cancer cells
Comparison
Concomitant treatment with CAPE plus DXR or CDDP vs DXR or CDDP alone
Design
In vitro preclinical laboratory study
Authors
Loading...
May support CAPE as chemotherapy sensitizer in gastric/colon cancers; hypothesis-generating from animal data only.
Does CAPE enhance the sensitivity of gastric and colon cancer cells to doxorubicin and cisplatin?
CAPE enhances the sensitivity of gastric and colon cancer cells to doxorubicin and cisplatin by decreasing proteasome function, suggesting potential as an adjuvant in chemotherapy.
Matsunaga et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: